| Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues CJ Meehan, GA Goig, TA Kohl, L Verboven, A Dippenaar, M Ezewudo, ... NATURE reviews microbiology 17 (9), 533-545, 2019 | 369 | 2019 |
| Putative Compensatory Mutations in the rpoC Gene of Rifampin-Resistant Mycobacterium tuberculosis Are Associated with Ongoing Transmission M De Vos, B Müller, S Borrell, PA Black, PD Van Helden, RM Warren, ... Antimicrobial agents and chemotherapy 57 (2), 827-832, 2013 | 274 | 2013 |
| Diagnostic accuracy of two commercial SARS-CoV-2 antigen-detecting rapid tests at the point of care in community-based testing centers A Berger, MTN Nsoga, FJ Perez-Rodriguez, YA Aad, P Sattonnet-Roche, ... Plos one 16 (3), e0248921, 2021 | 149 | 2021 |
| Evaluation of the accuracy, ease of use and limit of detection of novel, rapid, antigen-detecting point-of-care diagnostics for SARS-CoV-2 LJ Krüger, M Gaeddert, L Koeppel, LE Brümmer, C Gottschalk, IB Miranda, ... medRxiv, 2020.10. 01.20203836, 2020 | 87 | 2020 |
| Whole genome sequencing reveals genomic heterogeneity and antibiotic purification in Mycobacterium tuberculosis isolates PA Black, M De Vos, GE Louw, RG Van der Merwe, A Dippenaar, ... BMC genomics 16, 1-14, 2015 | 85 | 2015 |
| Bedaquiline microheteroresistance after cessation of tuberculosis treatment M De Vos, SD Ley, KB Wiggins, B Derendinger, A Dippenaar, ... New England Journal of Medicine 380 (22), 2178-2180, 2019 | 60 | 2019 |
| Deciphering Within-Host Microevolution of Mycobacterium tuberculosis through Whole-Genome Sequencing: the Phenotypic Impact and Way Forward SD Ley, M de Vos, A Van Rie, RM Warren Microbiology and Molecular Biology Reviews 83 (2), 10.1128/mmbr. 00062-18, 2019 | 55 | 2019 |
| Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin GR Davies, M Chaplin, M De Vos, SG Schumacher, R Warren, G Theron Cochrane Database of Systematic Reviews, 2022 | 51 | 2022 |
| Head-to-head performance comparison of self-collected nasal versus professional-collected nasopharyngeal swab for a WHO-listed SARS-CoV-2 antigen-detecting rapid diagnostic test JAF Klein, LJ Krüger, F Tobian, M Gaeddert, F Lainati, P Schnitzler, ... Medical microbiology and immunology 210 (4), 181-186, 2021 | 48 | 2021 |
| Diagnostic accuracy and utility of FluoroType MTBDR, a new molecular assay for multidrug-resistant tuberculosis M de Vos, B Derendinger, T Dolby, J Simpson, PD van Helden, JE Rice, ... Journal of clinical microbiology 56 (9), 10.1128/jcm. 00531-18, 2018 | 48 | 2018 |
| Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: An antigen-detecting point-of-care device for SARS-CoV-2 LJ Krüger, JAF Klein, F Tobian, M Gaeddert, F Lainati, S Klemm, ... Infection 50 (2), 395-406, 2022 | 43 | 2022 |
| Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2 MT Ngo Nsoga, I Kronig, FJ Perez Rodriguez, P Sattonnet-Roche, ... PLoS One 16 (6), e0253321, 2021 | 43 | 2021 |
| Accuracy and ease-of-use of seven point-of-care SARS-CoV-2 antigen-detecting tests: a multi-centre clinical evaluation LJ Krüger, A Tanuri, AK Lindner, M Gaeddert, L Köppel, F Tobian, ... EBioMedicine 75, 2022 | 40 | 2022 |
| The Abbott PanBio WHO emergency use listed, rapid, antigen-detecting point-of-care diagnostic test for SARS-CoV-2—Evaluation of the accuracy and ease-of-use LJ Krüger, M Gaeddert, F Tobian, F Lainati, C Gottschalk, JAF Klein, ... PLoS One 16 (5), e0247918, 2021 | 40 | 2021 |
| A landscape of genomic alterations at the root of a near-untreatable tuberculosis epidemic M Klopper, TH Heupink, G Hill-Cawthorne, EM Streicher, A Dippenaar, ... BMC medicine 18, 1-14, 2020 | 28 | 2020 |
| Comparative analytical evaluation of four centralized platforms for the detection of Mycobacterium tuberculosis complex and resistance to rifampicin and isoniazid M de Vos, L Scott, A David, A Trollip, H Hoffmann, S Georghiou, ... Journal of Clinical Microbiology 59 (3), 10.1128/jcm. 02168-20, 2021 | 24 | 2021 |
| Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study B Derendinger, A Dippenaar, M de Vos, S Huo, R Alberts, R Tadokera, ... The Lancet Microbe 4 (12), e972-e982, 2023 | 20 | 2023 |
| Analytical performance of the Xpert MTB/XDR® assay for tuberculosis and expanded resistance detection SB Georghiou, A Penn-Nicholson, M de Vos, A Macé, MW Syrmis, ... Diagnostic microbiology and infectious disease 101 (1), 115397, 2021 | 20 | 2021 |
| Whole genome sequencing provides additional insights into recurrent tuberculosis classified as endogenous reactivation by IS6110 DNA fingerprinting A Dippenaar, M De Vos, FM Marx, SA Adroub, PD van Helden, A Pain, ... Infection, Genetics and Evolution 75, 103948, 2019 | 19 | 2019 |
| Mycobacterial genomic DNA from used Xpert MTB/RIF cartridges can be utilised for accurate second-line genotypic drug susceptibility testing and spoligotyping R Venter, B Derendinger, M De Vos, S Pillay, T Dolby, J Simpson, ... Scientific reports 7 (1), 14854, 2017 | 17 | 2017 |
